未登录

C

Cheng Zhou

Zhongshan Hospital

H指数:20

被引数:1,452

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-intrinsic stratifin contributes to NECTIN2–TIGIT-mediated NK-cell suppression and therapeutic vulnerability in intrahepatic cholangiocarcinoma

肿瘤内源性Stratifin参与NECTIN2–TIGIT介导的NK细胞抑制及肝内胆管癌的治疗易感性

Journal of Translational Medicine

IF7.5

2026-10-220

OAAI

Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression

雄激素剥夺疗法后升高的VRK1水平通过上调YAP1表达促进前列腺癌进展

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

IF2.8

2025-03-200

OA

In reply to dexmedetomidine's role in inflammation and pain post video-assisted thoracoscopic surgery for lung

IF2.7

2025-02-010

PRE

Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1

HEPATOLOGY INTERNATIONAL

IF6.1

2023-04-2812

PRE

Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Carcinoma

Lenvatinib诱导免疫原性细胞死亡并触发癌症中的Toll样受体3/4配体

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2023-04-0117

OAAI

Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution

IF3.6

2022-12-019

OAAI

Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study

Lenvatinib联合anti-PD-1治疗对最初不可切除的肝细胞癌患者是一种可行的转换切除策略: 一项回顾性研究

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-2426

OAAI

Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression

IF3.9

2022-08-198

OAAI

EGFR amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcome

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-018

OAAI

Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing

IF3.4

2022-05-2510

OAAI

BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression

DIGESTIVE AND LIVER DISEASE

IF3.8

2022-05-0112

PRE

A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-271

OAAI

Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-04-2620

OAAI

Development and validation of a non-invasive model for diagnosing HBV-related liver cirrhosis

HBV相关肝硬化无创诊断模型的建立与验证

CLINICA CHIMICA ACTA

IF2.9

2021-12-016

OAAI

Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis

IF7.3

2021-03-1918

PREAI

Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis

CELL DEATH & DISEASE

IF9.6

2021-03-1183

OAAI

MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β-catenin and predicts poor prognosis

LIVER INTERNATIONAL

IF5.2

2021-02-167

PREAI

Comprehensive genomic insights into dynamic mechanism underlying the development of non-malignant human liver disease into hepatocellular carcinoma

CANCER RESEARCH

IF16.6

2020-08-150

PRE

ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5

IF3.7

2020-05-0116

PREAI

Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: a multicenter retrospective study

IF3.9

2019-12-127

OAAI